Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: Potential therapeutic targeting

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a beta coronavirus that uses the human angiotensin-converting enzyme 2 (ACE2) receptor as a point of entry. The present review discusses the origin and structure of the virus and its mechanism of cell entry followed by the therapeutic p...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Eur J Pharmacol
Main Authors: Sharifkashani, Sourena, Bafrani, Melika Arab, Khaboushan, Alireza Soltani, Pirzadeh, Marzieh, Kheirandish, Ali, Yavarpour_Bali, Hanie, Hessami, Amirhossein, Saghazadeh, Amene, Rezaei, Nima
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier B.V. 2020
Assuntos:
Full Length Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7834210/
https://ncbi.nlm.nih.gov/pubmed/32745604
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejphar.2020.173455
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares